Antidepressant use and stroke or mortality risk in the elderly
- PMID: 34632668
- DOI: 10.1111/ene.15137
Antidepressant use and stroke or mortality risk in the elderly
Abstract
Background and purpose: Current evidence on antidepressant-related stroke or mortality risk is inconsistent. Because the elderly have the highest exposure to antidepressants, the aim was to quantify their association with stroke and mortality risks in this vulnerable population.
Methods: Persons over 65 years old and registered in the Information System for Research in Primary Care of Catalonia during 2010-2015 comprised the study population. Antidepressant exposure was categorized into current-users, recent-users, past-users and antidepressant non-users (controls). The effect of antidepressant exposure on stroke or death, whichever came first, was analyzed by Cox regression adjusted for established risk factors.
Results: Of the 1,068,117 participants included, 20% had antidepressant reimbursements during follow-up, 17% had a stroke and 3% died. The risk of experiencing stroke or death was higher in antidepressant current-users (hazard ratio [HR] 1.04; 95% confidence interval [CI] 1.02-1.06), recent-users (HR 3.34; 95% CI 3.27-3.41) and past-users (HR 2.06; 95% CI 2.02-2.10) compared to antidepressant non-users. Antidepressant current-use was associated with increased stroke (HR 1.56; 95% CI 1.50-1.61) but decreased mortality risk (HR 0.93; 95% CI 0.91-0.94). During antidepressant recent-use and past-use, both stroke and mortality risks were significantly increased compared to no antidepressant use.
Conclusions: Antidepressant use may be associated with increased stroke risk in the elderly. When using antidepressants in this population, the potential risks should be considered.
Keywords: aged; antidepressive agents; mortality; pharmacoepidemiology; stroke.
© 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
References
REFERENCES
-
- Abbing-Karahagopian V, Huerta C, Souverein PC, et al. Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. 2014;70(7):849-857. https://doi.org/10.1007/s00228-014-1676-z
-
- Gomez-Lumbreras A, Ferrer P, Ballarín E, et al. Study of antidepressant use in 5 European settings. Could economic, sociodemographic and cultural determinants be related to their use? J Affect Disord. 2019;249:278-285. https://doi.org/10.1016/j.jad.2019.01.039
-
- Carrasco-Garrido P, López de Andrés A, Hernández Barrera V, Jiménez-Trujillo I, Jiménez-García R. National trends (2003-2009) and factors related to psychotropic medication use in community-dwelling elderly population. Int Psychogeriatr. 2013;25(2):328-338. https://doi.org/10.1017/S104161021200169X
-
- Schwarz S, Frölich L. Depression. In: Wehling M, ed. Drug Therapy for the Elderly. Springer-Verlag; 2013:197-213.
-
- Tham A, Jonsson U, Andersson G, Soderlund A, Allard P, Bertilsson G. Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive disorder-a systematic review and a meta-analysis. J Affect Disord. 2016;205:1-12. https://doi.org/10.1016/j.jad.2016.06.013
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous